Author:
Butragueño-Laiseca Laura,Manrique Martín Gema,González Cortés Rafael,Rey Galán Corsino,Martínez de Compañón Martínez de Ma Zuriñe,Gil Antón Javier,Rodríguez Núñez Antonio,M Fernández-Llamazares Cecilia,Manrique-Rodríguez Silvia,López-Herce Cid Jesús
Abstract
AbstractTo analyze the effectiveness of dexamethasone in preventing upper airway obstruction (UAO) symptoms after extubation and the need of reintubation in critically ill children. Multicenter, prospective, double-blind, randomized, phase IV clinical trial involving five pediatric intensive care units. Children between 1 month and 16 years-of-age intubated for more than 48 h were included. Patients were randomized to receive placebo or dexamethasone 0.25 mg/kg every 6 h, 6-to-12 h prior to extubation (four doses). 48 h follow-up was carried out after extubation. Severity of UAO symptoms (Taussig score, stridor) and reintubation requirement were compared. 147 patients were randomized (10 were excluded), 70 patients received dexamethasone and 67 placebo. No global differences were found in the presence of stridor or moderate-to-severe UAO symptoms (Taussig ≥ 5), but Taussig ≥ 5 was less frequent in patients less than 2 years-of-age treated with steroids (p = 0.014). Median Taussig score was lower in the dexamethasone group 1 h after extubation, p < 0.001. 27 patients required reintubation, 9 due to UAO: 3 (4.3%) in the dexamethasone group and 6 (8.9%) in the placebo group, p = 0.319. In those intubated > 5 days, reintubation due to UAO was higher in the placebo group (2.4% vs. 14.3, p = 0.052). Nebulized epinephrine and budesonide were required more frequently in the placebo group in the first 2 h (p = 0.041) and 1 h (p = 0.02) after extubation, respectively. No relevant side effects were observed. Dexamethasone prior to extubation did not significantly reduce moderate-severe UAO symptoms, except for patients under 2-years of age. Dexamethasone could decrease Taussig score and the need of rescue therapies, as well as reintubation rates in those intubated for more than 5 days.
Funder
Instituto de Salud Carlos III
Publisher
Springer Science and Business Media LLC
Reference21 articles.
1. Kurachek, S. C. et al. Extubation failure in pediatric intensive care: A multiple-center study of risk factors and outcomes. Crit. Care Med. 31, 2657–2664 (2003).
2. Khemani, R. G. et al. Evaluating risk factors for pediatric post-extubation upper airway obstruction using a physiology-based tool. Am. J. Respir. Crit. Care Med. 193, 198–209 (2016).
3. Baranwal, A. K., Meena, J. P., Singhi, S. C. & Muralidharan, J. Dexamethasone pretreatment for 24 h versus 6 h for prevention of postextubation airway obstruction in children: A randomized double-blind trial. Intensive Care Med. 40, 1285–1294 (2014).
4. Khemani, R. G., Randolph, A. & Markovitz, B. Corticosteroids for the prevention and treatment of post-extubation stridor in neonates, children and adults. Cochrane Database Syst. Rev. https://doi.org/10.1002/14651858.CD001000.pub3 (2009).
5. Malhotra, D., Gurcoo, S., Qazi, S. & Gupta, S. Randomized comparative efficacy of dexamethasone to prevent postextubation upper airway complications in children and adults in ICU. Indian J. Anaesth. 53, 442–449 (2009).
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献